secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001493152-25-001711
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi refiles FY2023 financials to reflect 1-for-10 reverse stock split
------------------------------------------------------------------------

- 1-for-10 reverse stock split effective July 15, 2024, retroactively applied to FY2023 statements.
- Exhibits incorporated by reference from December 12, 2024 S-1; no change to non-split information.
- All other 2023 Annual Report information remains unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225001711/0001493152-25-001711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225001711/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer